Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - OTHER CURRENT LIABILITIES
Other Current Liabilities LRMR - Larimar Therapeutics, Inc.
7.39 M
LAST VALUE
10.97%
2 YEAR CAGR
1.25%
5 YEAR CAGR
9.74%
10 YEAR CAGR